Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker HSIC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | William K. Daniel Director | HSIC Henry Schein, Inc. | Buy | 10,000 | $69.19 | $691.9K Buy | Form 4 ↗ |
| Mar 19, 2026 | Thomas C. Popeck CEO, Henry Schein Products | HSIC Henry Schein, Inc. | Sale | 1,355 | $72.79 | $98.6K Sale | Form 4 ↗ |
| Mar 10, 2026 | Kurt P. Kuehn Director | HSIC Henry Schein, Inc. | Sale | 2,844 | $78.96 | $224.6K Sale | Form 4 ↗ |
| Mar 5, 2026 | Philip A. Laskawy Director | HSIC Henry Schein, Inc. | Sale | 2,844 | $80.36 | $228.5K Sale | Form 4 ↗ |
| Mar 4, 2026 | Mark E. Mlotek EVP, Chief Strategic Officer | HSIC Henry Schein, Inc. | Sale | 1,825 | $80.81 | $147.5K Sale | Form 4 ↗ |
| Mar 4, 2026 | Mark E. Mlotek EVP, Chief Strategic Officer | HSIC Henry Schein, Inc. | Sale | 4,100 | $80.80 | $331.3K Sale | Form 4 ↗ |
| Mar 2, 2026 | Stanley M. Bergman Chairman, CEO, Director | HSIC Henry Schein, Inc. | Sale | 19,954 | $81.31 | $1.6M Sale | Form 4 ↗ |
| Mar 2, 2026 | Stanley M. Bergman Chairman, CEO, Director | HSIC Henry Schein, Inc. | Sale | 23,858 | $81.31 | $1.9M Sale | Form 4 ↗ |
| Feb 27, 2026 | Stanley M. Bergman Chairman, CEO, Director | HSIC Henry Schein, Inc. | Sale | 10,785 | $81.20 | $875.7K Sale | Form 4 ↗ |
| Feb 26, 2026 | Stanley M. Bergman Chairman, CEO, Director | HSIC Henry Schein, Inc. | Sale | 7,212 | $81.51 | $587.9K Sale | Form 4 ↗ |
| Feb 26, 2026 | Stanley M. Bergman Chairman, CEO, Director | HSIC Henry Schein, Inc. | Sale | 31,134 | $80.90 | $2.5M Sale | Form 4 ↗ |
| Aug 7, 2025 | William K. Daniel Director | HSIC Henry Schein, Inc. | Buy | 10,000 | $67.08 | $670.8K Buy | Form 4 ↗ |
| Mar 19, 2025 | Philip A. Laskawy Director | HSIC Henry Schein, Inc. | Sale | 2,604 | $71.04 | $185.0K Sale | Form 4 ↗ |
| Mar 19, 2025 | Bradford C. Connett CEO, NA Distribution Group | HSIC Henry Schein, Inc. | Sale | 4,036 | $71.15 | $287.2K Sale | Form 4 ↗ |
| Mar 5, 2025 | Kurt P. Kuehn Director | HSIC Henry Schein, Inc. | Sale | 2,787 | $71.55 | $199.4K Sale | Form 4 ↗ |
| Nov 18, 2024 | Michael S. Ettinger EVP & Chief Operating Officer | HSIC Henry Schein, Inc. | Sale | 12,240 | $75.00 | $918.0K Sale | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances